-
1
-
-
0026549678
-
Increased plasma levels of endothelin in diabetic patients with hypertension
-
Haak T, Jungmann E, Felber A, Hillmann U, Usadel KH: Increased plasma levels of endothelin in diabetic patients with hypertension. Am J Hypertens 5:161-166, 1992
-
(1992)
Am J Hypertens
, vol.5
, pp. 161-166
-
-
Haak, T.1
Jungmann, E.2
Felber, A.3
Hillmann, U.4
Usadel, K.H.5
-
2
-
-
0025361407
-
Elevated plasma endothelin in patients with diabetes mellitus
-
Takahashi K, Ghatei MA, Lam HC, O'Halloran DJ, Bloom SR: Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 33:306-310, 1990
-
(1990)
Diabetologia
, vol.33
, pp. 306-310
-
-
Takahashi, K.1
Ghatei, M.A.2
Lam, H.C.3
O'Halloran, D.J.4
Bloom, S.R.5
-
3
-
-
0033964675
-
Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetes
-
Gilbert RE, Rumble JR, Cao Z, Cox AJ, van Eeden P, Allen TJ, Kelly DJ, Cooper ME: Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetes. Circ Res 86:158-165, 2000
-
(2000)
Circ Res
, vol.86
, pp. 158-165
-
-
Gilbert, R.E.1
Rumble, J.R.2
Cao, Z.3
Cox, A.J.4
van Eeden, P.5
Allen, T.J.6
Kelly, D.J.7
Cooper, M.E.8
-
4
-
-
21744437756
-
Endothelin-mediated remodeling in aortas of diabetic rats
-
Fukuda G, Khan ZA, Barbin YP, Farhangkhoee H, Tilton RG, Chakrabarti S: Endothelin-mediated remodeling in aortas of diabetic rats. Diabetes Metab Res Rev 21:367-375, 2005
-
(2005)
Diabetes Metab Res Rev
, vol.21
, pp. 367-375
-
-
Fukuda, G.1
Khan, Z.A.2
Barbin, Y.P.3
Farhangkhoee, H.4
Tilton, R.G.5
Chakrabarti, S.6
-
5
-
-
33644871367
-
Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes
-
Portik-Dobos V, Harris AK, Song W, Hutchinson J, Johnson MH, Imig JD, Pollock DM, Ergul A: Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes. Am J Physiol 290:R435-R441, 2005
-
(2005)
Am J Physiol
, vol.290
-
-
Portik-Dobos, V.1
Harris, A.K.2
Song, W.3
Hutchinson, J.4
Johnson, M.H.5
Imig, J.D.6
Pollock, D.M.7
Ergul, A.8
-
6
-
-
24144442641
-
Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: Role of endothelin-1
-
Harris AK, Hutchinson JR, Sachidanandam K, Johnson MH, Dorrance AM, Stepp DW, Fagan SC, Ergul A: Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1. Diabetes 54:2638-2644, 2005
-
(2005)
Diabetes
, vol.54
, pp. 2638-2644
-
-
Harris, A.K.1
Hutchinson, J.R.2
Sachidanandam, K.3
Johnson, M.H.4
Dorrance, A.M.5
Stepp, D.W.6
Fagan, S.C.7
Ergul, A.8
-
7
-
-
0028987867
-
Possible role of endothelin in endothelial regulation of vascular tone
-
Masaki T: Possible role of endothelin in endothelial regulation of vascular tone. Annu Rev Pharmacol Toxicol 35:235-255, 1995
-
(1995)
Annu Rev Pharmacol Toxicol
, vol.35
, pp. 235-255
-
-
Masaki, T.1
-
8
-
-
0037044398
-
Vascular endothelin-B receptor system in vivo plays a favorable inhibitory role in vascular remodeling after injury revealed by endothelin-B receptor-knockout mice
-
Murakoshi N, Miyauchi T, Kakinuma Y, Ohuchi T, Goto K, Yanagisawa M, Yamaguchi I: Vascular endothelin-B receptor system in vivo plays a favorable inhibitory role in vascular remodeling after injury revealed by endothelin-B receptor-knockout mice. Circulation 106:1991-1998, 2002
-
(2002)
Circulation
, vol.106
, pp. 1991-1998
-
-
Murakoshi, N.1
Miyauchi, T.2
Kakinuma, Y.3
Ohuchi, T.4
Goto, K.5
Yanagisawa, M.6
Yamaguchi, I.7
-
9
-
-
0037693895
-
Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry
-
Visse R, Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92: 827-839, 2003
-
(2003)
Circ Res
, vol.92
, pp. 827-839
-
-
Visse, R.1
Nagase, H.2
-
10
-
-
0036175568
-
Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: Role of ET(A) receptors
-
Ammarguellat FZ, Gannon PO, Amiri F, Schiffrin EL: Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: role of ET(A) receptors. Hypertension 39:679-684, 2002
-
(2002)
Hypertension
, vol.39
, pp. 679-684
-
-
Ammarguellat, F.Z.1
Gannon, P.O.2
Amiri, F.3
Schiffrin, E.L.4
-
11
-
-
33645641243
-
Type-2 diabetes-induced changes in vascular extracellular matrix gene expression: Relation to vessel size
-
Song W, Ergul A: Type-2 diabetes-induced changes in vascular extracellular matrix gene expression: relation to vessel size. Cardiovasc Diabetol 5:3, 2006
-
(2006)
Cardiovasc Diabetol
, vol.5
, pp. 3
-
-
Song, W.1
Ergul, A.2
-
12
-
-
33748793365
-
Mice lacking the gene encoding for MMP-9 and resistance artery reactivity
-
Su J, Palen DI, Lucchesi PA, Matrougui K: Mice lacking the gene encoding for MMP-9 and resistance artery reactivity. Biochem Biophys Res Commun 349:1177-1181, 2006
-
(2006)
Biochem Biophys Res Commun
, vol.349
, pp. 1177-1181
-
-
Su, J.1
Palen, D.I.2
Lucchesi, P.A.3
Matrougui, K.4
-
13
-
-
10044256495
-
Involvement of metalloproteinases 2/9 in epidermal growth factor receptor transactivation in pressure-induced myogenic tone in mouse mesenteric resistance arteries
-
Lucchesi PA, Sabri A, Belmadani S, Matrougui K: Involvement of metalloproteinases 2/9 in epidermal growth factor receptor transactivation in pressure-induced myogenic tone in mouse mesenteric resistance arteries. Circulation 110:3587-3593, 2004
-
(2004)
Circulation
, vol.110
, pp. 3587-3593
-
-
Lucchesi, P.A.1
Sabri, A.2
Belmadani, S.3
Matrougui, K.4
-
14
-
-
2942530449
-
Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver: Contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high fat-induced insulin-resistant states
-
Standaert ML, Sajan MP, Miura A, Kanoh Y, Chen HC, Farese RV Jr, Farese RV: Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver: contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high fat-induced insulin-resistant states. J Biol Chem 279:24929-24934, 2004
-
(2004)
J Biol Chem
, vol.279
, pp. 24929-24934
-
-
Standaert, M.L.1
Sajan, M.P.2
Miura, A.3
Kanoh, Y.4
Chen, H.C.5
Farese Jr, R.V.6
Farese, R.V.7
-
15
-
-
0028063717
-
Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats
-
Farese RV, Standaert ML, Yamada K, Huang LC, Zhang C, Cooper DR, Wang Z, Yang Y, Suzuki S, Toyota T, et al.: Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats. Proc Natl Acad Sci U S A 91:11040-11044, 1994
-
(1994)
Proc Natl Acad Sci U S A
, vol.91
, pp. 11040-11044
-
-
Farese, R.V.1
Standaert, M.L.2
Yamada, K.3
Huang, L.C.4
Zhang, C.5
Cooper, D.R.6
Wang, Z.7
Yang, Y.8
Suzuki, S.9
Toyota, T.10
-
16
-
-
0036670253
-
Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: Ex vivo and in vivo studies
-
Wessale JL, Adler AL, Novosad EI, Calzadilla SV, Dayton BD, Marsh KC, Winn M, Jae HS, Geldern TW, Opgenorth TJ, Wu-Wong JR: Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: ex vivo and in vivo studies. Clin Sci (Lond) 103 (Suppl. 1):112S-117S, 2002
-
(2002)
Clin Sci (Lond)
, vol.103
, Issue.SUPPL. 1
-
-
Wessale, J.L.1
Adler, A.L.2
Novosad, E.I.3
Calzadilla, S.V.4
Dayton, B.D.5
Marsh, K.C.6
Winn, M.7
Jae, H.S.8
Geldern, T.W.9
Opgenorth, T.J.10
Wu-Wong, J.R.11
-
17
-
-
0036670253
-
Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: Ex vivo and in vivo studies
-
Wessale JL, Adler AL, Novosad EI, Calzadilla SV, Dayton BD, Marsh KC, Winn M, Jae HS, von Geldern TW, Opgenorth TJ, Wu-Wong JR: Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: ex vivo and in vivo studies. Clin Sci (Lond) 103 (Suppl. 48):112S-117S, 2002
-
(2002)
Clin Sci (Lond)
, vol.103
, Issue.SUPPL. 48
-
-
Wessale, J.L.1
Adler, A.L.2
Novosad, E.I.3
Calzadilla, S.V.4
Dayton, B.D.5
Marsh, K.C.6
Winn, M.7
Jae, H.S.8
von Geldern, T.W.9
Opgenorth, T.J.10
Wu-Wong, J.R.11
-
18
-
-
0142169962
-
Stress upregulates arterial matrix metalloproteinase expression and activity via endothelin A receptor activation
-
Ergul A, Portik-Dobos V, Giulumian AD, Molero MM, Fuchs LC: Stress upregulates arterial matrix metalloproteinase expression and activity via endothelin A receptor activation. Am J Physiol 285:H2225-H2232, 2003
-
(2003)
Am J Physiol
, vol.285
-
-
Ergul, A.1
Portik-Dobos, V.2
Giulumian, A.D.3
Molero, M.M.4
Fuchs, L.C.5
-
19
-
-
84944661914
-
Rank transformations as a bridge between parametric and nonparametric statistics
-
Conover W, Iman R: Rank transformations as a bridge between parametric and nonparametric statistics. Am Stat 35:124-133, 1981
-
(1981)
Am Stat
, vol.35
, pp. 124-133
-
-
Conover, W.1
Iman, R.2
-
20
-
-
0030907178
-
Vascular hypertrophy in experimental diabetes: Role of advanced glycation end products
-
Rumble JR, Cooper ME, Cox AJ, Soulis T, Wu L, Youssef S, Jasik M, Jerums G, Gilbert RE: Vascular hypertrophy in experimental diabetes: role of advanced glycation end products. J Clin Invest 99:1016-1027, 1997
-
(1997)
J Clin Invest
, vol.99
, pp. 1016-1027
-
-
Rumble, J.R.1
Cooper, M.E.2
Cox, A.J.3
Soulis, T.4
Wu, L.5
Youssef, S.6
Jasik, M.7
Jerums, G.8
Gilbert, R.E.9
-
21
-
-
5644247979
-
Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction
-
Amiri F, Virdis A, Neves MF, Iglarz M, Seidah N, Touyz R, Reudelhuber T, Schiffrin EL: Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction. Circulation 110:2233-2240, 2004
-
(2004)
Circulation
, vol.110
, pp. 2233-2240
-
-
Amiri, F.1
Virdis, A.2
Neves, M.F.3
Iglarz, M.4
Seidah, N.5
Touyz, R.6
Reudelhuber, T.7
Schiffrin, E.L.8
-
22
-
-
0032769379
-
Cellular mechanisms of diabetic vascular hypertrophy
-
Vranes D, Cooper ME, Dilley RJ: Cellular mechanisms of diabetic vascular hypertrophy. Microvasc Res 57:8-18, 1999
-
(1999)
Microvasc Res
, vol.57
, pp. 8-18
-
-
Vranes, D.1
Cooper, M.E.2
Dilley, R.J.3
-
23
-
-
0035721934
-
Injury induces dedifferentiation of smooth muscle cells and increased matrix-degrading metalloproteinase activity in human saphenous vein
-
Johnson JL, van Eys GJ, Angelini GD, George SJ: Injury induces dedifferentiation of smooth muscle cells and increased matrix-degrading metalloproteinase activity in human saphenous vein. Arterioscler Thromb Vasc Biol 21:1146-1151, 2001
-
(2001)
Arterioscler Thromb Vasc Biol
, vol.21
, pp. 1146-1151
-
-
Johnson, J.L.1
van Eys, G.J.2
Angelini, G.D.3
George, S.J.4
-
24
-
-
0034015695
-
Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosis
-
George SJ: Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosis. Expert Opin Investig Drugs 9:993-1007, 2000
-
(2000)
Expert Opin Investig Drugs
, vol.9
, pp. 993-1007
-
-
George, S.J.1
-
25
-
-
0031773610
-
Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques
-
Johnson JL, Jackson CL, Angelini GD, George SJ: Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 18:1707-1715, 1998
-
(1998)
Arterioscler Thromb Vasc Biol
, vol.18
, pp. 1707-1715
-
-
Johnson, J.L.1
Jackson, C.L.2
Angelini, G.D.3
George, S.J.4
-
26
-
-
0038061562
-
A central role of EGF receptor transactivation in angiotensin II-induced cardiac hypertrophy
-
Shah BH, Catt KJ: A central role of EGF receptor transactivation in angiotensin II-induced cardiac hypertrophy. Trends Pharmacol Sci 24: 239-244, 2003
-
(2003)
Trends Pharmacol Sci
, vol.24
, pp. 239-244
-
-
Shah, B.H.1
Catt, K.J.2
-
27
-
-
0042317115
-
Epidermal growth factor receptor transactivation is regulated by glucose in vascular smooth muscle cells
-
Konishi A, Berk BC: Epidermal growth factor receptor transactivation is regulated by glucose in vascular smooth muscle cells. J Biol Chem 278:35049-35056, 2003
-
(2003)
J Biol Chem
, vol.278
, pp. 35049-35056
-
-
Konishi, A.1
Berk, B.C.2
-
28
-
-
0035146135
-
Transactivation: A novel signaling pathway from angiotensin II to tyrosine kinase receptors
-
Saito Y, Berk BC: Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors. J Mol Cell Cardiol 33:3-7, 2001
-
(2001)
J Mol Cell Cardiol
, vol.33
, pp. 3-7
-
-
Saito, Y.1
Berk, B.C.2
-
29
-
-
0037313307
-
Epidermal growth factor receptor trans-activation mediates the tonic and fibrogenic effects of endothelin in the aortic wall of transgenic mice
-
Flamant M, Tharaux PL, Placier S, Henrion D, Coffman T, Chatziantoniou C, Dussaule JC: Epidermal growth factor receptor trans-activation mediates the tonic and fibrogenic effects of endothelin in the aortic wall of transgenic mice. FASEB J 17:327-329, 2003
-
(2003)
FASEB J
, vol.17
, pp. 327-329
-
-
Flamant, M.1
Tharaux, P.L.2
Placier, S.3
Henrion, D.4
Coffman, T.5
Chatziantoniou, C.6
Dussaule, J.C.7
|